Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.ajantapharma.com | |
Market Cap | 23,760.91 Cr. | |
Enterprise Value(EV) | 23,998.94 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 52.43 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 35.99 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.52 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 276.52 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 6.82 | Calculated using Price: 1,887.05 |
Dividend Yield | 0.37 | Period Ending 2023-03 |
No. of Shares Subscribed | 12.59 Cr. | 125,915,655 Shares |
FaceValue | 2 | |
About Ajanta Pharma Ltd. | ||
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. Emerging markets are the major contributors in company's branded generic business where it is present across Asia and Africa. It has designed customised basket of products for each of these markets and serve wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products. |
1 Day |
|
-1.44% |
1 Week |
|
-3.20% |
1 Month |
|
+5.49% |
3 Month |
|
+9.84% |
6 Month |
|
+29.37% |
1 Year |
|
+54.07% |
2 Year |
|
+35.98% |
5 Year |
|
+172.04% |
10 Year |
|
+652.62% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 43.24 | 40.93 | 36.77 | 26.00 | 18.07 | 19.32 | 23.38 | 22.77 | 17.68 | |
Return on Capital Employed (%) | 56.43 | 51.59 | 45.72 | 34.49 | 23.84 | 27.44 | 32.20 | 29.37 | 22.57 | |
Return on Assets (%) | 29.57 | 31.66 | 30.69 | 22.06 | 14.52 | 14.44 | 17.03 | 17.16 | 13.21 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 841 | 1,191 | 1,568 | 2,041 | 2,245 | 2,599 | 2,996 | 3,264 | 3,388 | 3,482 | |
Non Curr. Liab. | 56 | 29 | 9 | 39 | 162 | 228 | 275 | 285 | 177 | 18 | |
Curr. Liab. | 250 | 260 | 247 | 346 | 498 | 746 | 839 | 647 | 1,139 | 799 | |
Minority Int. | |||||||||||
Equity & Liab. | 1,146 | 1,479 | 1,823 | 2,426 | 2,906 | 3,572 | 4,109 | 4,197 | 4,705 | 4,299 | |
Non Curr. Assets | 513 | 716 | 973 | 1,202 | 1,605 | 1,791 | 1,891 | 1,932 | 1,871 | 1,737 | |
Curr. Assets | 633 | 763 | 851 | 1,224 | 1,301 | 1,781 | 2,218 | 2,264 | 2,825 | 2,563 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,146 | 1,479 | 1,823 | 2,426 | 2,906 | 3,572 | 4,109 | 4,197 | 4,705 | 4,299 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 1,474 | 1,734 | 1,983 | 2,126 | 2,055 | 2,588 | 2,890 | 3,341 | 3,743 | 3,903 | |
Other Income | 17 | 21 | 24 | 24 | 21 | 92 | 26 | 116 | 99 | 125 | |
Total Income | 1,490 | 1,755 | 2,007 | 2,150 | 2,076 | 2,680 | 2,916 | 3,457 | 3,841 | 4,028 | |
Total Expenditure | -968 | -1,147 | -1,296 | -1,467 | -1,489 | -1,905 | -1,891 | -2,412 | -2,959 | -3,022 | |
PBIDT | 522 | 608 | 711 | 683 | 588 | 776 | 1,025 | 1,045 | 882 | 1,006 | |
Interest | -6 | -5 | -1 | 0 | -1 | -12 | -8 | -10 | -6 | -7 | |
Depreciation | -52 | -44 | -61 | -60 | -72 | -96 | -116 | -125 | -131 | -133 | |
Taxation | -146 | -143 | -141 | -154 | -127 | -196 | -246 | -197 | -157 | -205 | |
Exceptional Items | -8 | -4 | |||||||||
PAT | 310 | 416 | 507 | 469 | 387 | 468 | 654 | 713 | 588 | 660 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 310 | 416 | 507 | 469 | 387 | 468 | 654 | 713 | 588 | 660 | |
Adjusted EPS | 23 | 31 | 38 | 36 | 30 | 36 | 50 | 56 | 47 | 52 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 212 | 279 | 326 | 609 | 281 | 375 | 457 | 576 | 562 | 792 | |
Cash Fr. Inv. | -188 | -158 | -209 | -383 | -256 | -223 | -224 | -282 | -74 | -560 | |
Cash Fr. Finan. | -20 | -105 | -117 | -202 | 0 | -147 | -129 | -318 | -460 | -108 | |
Net Change | 4 | 16 | 0 | 24 | 25 | 4 | 104 | -24 | 28 | 124 | |
Cash & Cash Eqvt | 39 | 54 | 41 | 66 | 91 | 95 | 199 | 178 | 205 | 331 |
Fri, 24 Nov 2023
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 23 2023 for Ravi Agrawal trustee Ravi Agrawal Trust |
Wed, 22 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate PFA herewith intimation w.r.t loss of share certificates |
Tue, 07 Nov 2023
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 07 2023 for Aayush Agrawal trustee Aayush Agrawal Trust |
Fri, 08 Dec 2023 |
|
|
|
|
|